Extendicare Financials

EXE Stock  CAD 10.33  0.03  0.29%   
You can utilize Extendicare fundamental data analysis to find out if markets are presently mispricing the company. We were able to analyze and collect data for thirty-seven available fundamental indicators for Extendicare, which can be compared to its peers. The stock experiences a normal upward fluctuation. Check odds of Extendicare to be traded at C$10.85 in 90 days. Key indicators impacting Extendicare's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income94.2 M111.8 M
Fairly Down
Slightly volatile
Current Ratio1.050.8266
Significantly Up
Very volatile
  
Understanding current and past Extendicare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Extendicare's financial statements are interrelated, with each one affecting the others. For example, an increase in Extendicare's assets may result in an increase in income on the income statement.

Extendicare Stock Summary

Extendicare Inc. provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. EXTENDICARE INC operates under Medical Care Facilities classification in Canada and is traded on Toronto Stock Exchange. It employs 22800 people.
Foreign Associate
  USA
Specialization
Health Care, Health Care Equipment & Services
InstrumentCanada Stock View All
ExchangeToronto Exchange
ISINCA30224T8639
Business Address3000 Steeles Avenue
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.extendicare.com
Phone905 470 4000
CurrencyCAD - Canadian Dollar
You should never invest in Extendicare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Extendicare Stock, because this is throwing your money away. Analyzing the key information contained in Extendicare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Extendicare Key Financial Ratios

Extendicare's financial ratios allow both analysts and investors to convert raw data from Extendicare's financial statements into concise, actionable information that can be used to evaluate the performance of Extendicare over time and compare it to other companies across industries.

Extendicare Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets888.8M963.1M900.3M781.6M672.7M1.2B
Other Current Liab9.1M23.4M16.1M7.9M6.2M5.9M
Net Debt459.4M384.6M432.2M216.7M259.3M246.4M
Accounts Payable131.4M168.0M189.1M242.2M197.1M140.6M
Net Receivables66.3M73.4M83.5M64.1M91.0M127.7M
Other Current Assets20.7M40.2M26.5M24.0M20.2M19.2M
Total Liab773.4M834.9M798.4M680.9M584.8M1.0B
Total Current Assets183.9M296.1M224.9M258.0M187.1M276.8M
Short Term Debt133.8M71.4M73.6M19.2M19.9M18.9M
Intangible Assets38.2M36.5M46.6M51.2M78.5M82.4M
Retained Earnings(382.2M)(371.0M)(402.5M)(384.6M)(393.5M)(413.1M)
Cash96.9M180.0M104.6M167.3M75.2M103.5M
Common Stock498.1M500.6M500.9M475.4M467.3M534.0M
Other Liab74.3M59.6M52.5M41.2M37.0M35.2M
Net Tangible Assets25.5M40.0M9.4M3.6M4.2M4.0M
Other Assets84.5M53.0M47.3M37.8M1.00.95
Long Term Debt422.5M493.2M463.3M364.7M314.6M373.8M
Short Long Term Debt133.8M71.4M73.6M19.2M19.9M18.9M
Long Term Debt Total422.5M493.2M463.3M364.7M328.3M355.2M
Capital Surpluse3.7M4.9M8.2M10.6M12.2M12.8M

Extendicare Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense28.7M28.5M27.2M20.6M21.6M20.5M
Total Revenue1.1B1.2B1.2B1.2B1.3B1.3B
Gross Profit93.7M197.7M151.7M76.8M118.4M112.5M
Operating Income52.4M93.3M56.6M21.0M111.8M94.2M
Ebit50.7M87.0M36.4M17.2M66.4M87.6M
Ebitda90.5M125.1M67.5M48.9M98.6M133.1M
Income Before Tax24.2M58.9M16.0M(4.5M)44.8M31.2M
Net Income17.1M42.6M9.0M(4.5M)34.0M29.9M
Income Tax Expense7.2M16.3M7.0M15K10.8M10.5M
Cost Of Revenue1.0B960.6M1.1B1.1B1.2B1.1B
Tax Provision7.2M16.3M7.0M15K10.8M6.9M
Interest Income23.0M29.0M23.7M15.5M6.2M5.9M
Extraordinary Items11.6M11.6M2.5M74.1M66.7M70.0M
Net Interest Income(26.9M)(27.0M)(25.0M)(15.3M)(15.5M)(16.3M)

Extendicare Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash28.6M85.5M(75.3M)62.7M(92.1M)(87.5M)
Free Cash Flow12.0M88.2M(6.1M)(2.9M)(106.1M)(100.8M)
Depreciation39.6M38.8M38.6M32.1M32.6M45.8M
Other Non Cash Items(27.0M)(12.3M)(10.5M)(59.6M)(10.3M)(9.8M)
Capital Expenditures33.2M33.1M69.5M101.6M129.4M135.9M
Net Income28.6M54.2M11.5M69.6M34.0M31.8M
End Period Cash Flow94.5M180.0M104.6M167.3M75.2M99.6M
Dividends Paid(37.2M)(41.3M)(43.0M)(42.6M)(40.4M)(42.5M)
Net Borrowings10.3M7.0M(30.0M)(114.2M)(102.8M)(97.7M)
Change To Netincome(19.3M)6.2M(283K)(57.0M)(51.3M)(48.8M)
Investments12.8M2.0M(63.7M)155.6M(84.5M)(80.2M)

Extendicare Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Extendicare's current stock value. Our valuation model uses many indicators to compare Extendicare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Extendicare competition to find correlations between indicators driving Extendicare's intrinsic value. More Info.
Extendicare is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.12  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Extendicare is roughly  8.38 . At this time, Extendicare's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Extendicare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Extendicare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Extendicare Systematic Risk

Extendicare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Extendicare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Extendicare correlated with the market. If Beta is less than 0 Extendicare generally moves in the opposite direction as compared to the market. If Extendicare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Extendicare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Extendicare is generally in the same direction as the market. If Beta > 1 Extendicare moves generally in the same direction as, but more than the movement of the benchmark.

Extendicare Total Assets Over Time

Today, most investors in Extendicare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Extendicare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Extendicare growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.0184)

At this time, Extendicare's Price Earnings To Growth Ratio is very stable compared to the past year.

Extendicare November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Extendicare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Extendicare. We use our internally-developed statistical techniques to arrive at the intrinsic value of Extendicare based on widely used predictive technical indicators. In general, we focus on analyzing Extendicare Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Extendicare's daily price indicators and compare them against related drivers.

Other Information on Investing in Extendicare Stock

Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.